Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Banyu’s Drug Ingredient Taken Off Anti-Doping List

This article was originally published in PharmAsia News

Executive Summary

Banyu announced Jan. 8 that androgenetic alopecia drug Propecia (finasteride) has been taken off the World Anti-Doping Agency's doping material list. In 2007, Softbank Hawks baseball player Rick Guttormson, who was using the drug to treat AGA, was barred from playing for 20 days and fined ¥7.5 million. WADA's decision to amend the list and take finasteride off is based on new analyzing technology that allows the agency to differentiate barred material from finasteride. (Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069800

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel